Drug could revolutionise treatment of spinal cord injury

"This drug has the potential to be a first-in-class treatment against some of the key pathological drivers of spinal cord injury and could revolutionise the prospects for recovery."

Related Keywords

United Kingdom ,British ,Zubair Ahmed ,Adam Thompson ,Sharif Alhajlah ,Rebecca Fairclough ,Rebeccaj Fairclough ,Adamm Thompson ,Astrazeneca ,Ophthalmology Department ,University Of Birmingham Enterprise ,University Of Birmingham ,Institute Of Inflammation ,Translational Medicine ,Professor Zubair Ahmed ,Ophthalmology Section ,Birmingham Enterprise ,Astrazeneca United Kingdom ,Emerging Innovations ,